The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

NCT06614985 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

172

Enrollment

OTHER

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: Telitacicept
DRUG: Prednisone
DRUG: Cyclophosphamide

Sponsor

Renmin Hospital of Wuhan University